Kommentar zu Art. 5, 6 und 7a HMG
[Commentary on Art. 5, 6 und 7a HMG]

by Michael Isler [co-author], Andreas Wildi [co-author] and Stephanie Eggimann [co-author]
in: Eichenberger/Jaisli/Richli (Editor[s]), "Basler Kommentar zum Heilmittelgesetz"
2, Basel, 2021

pdf 168 KB
Life Science Law Newsletter

Entry into force of the revised Swiss Medical Devices Ordinance and its implications for the medtech industry

by Andreas Wildi and Monja Sieber
May 2021

pdf 509 KB
Life Science Law Newsletter 3

Update: Postponement of EU Medical Device Regulation implementation due to COVID-19

by Andreas Wildi and Monja Sieber
May 2020

pdf 537 KB
Life Science Law Newsletter 3

Postponement of EU Medical Device Regulation implementation due to COVID-19

by Andreas Wildi and Monja Sieber
April 2020

Art. 40, 52, 52a KVG

by Andreas Wildi
Editor[s]: Blechta, Colatrella, Rüedi, Staffelbach
"Basler Kommentar - Krankenversicherungsgesetz, Krankenversicherungsaufsichtsgesetz"
2020

Die Abgrenzung von Lebensmitteln und Heilmitteln
[The distinction between food and therapeutic products]

by Andreas Wildi and Sophie Regenfuss
Editor[s]: Daniel Donauer/Hugh Reeves/Celine Weber
"Lebensmittel- und Gebrauchsgegenständerecht"
Zürich, 2020